BFC Planning’s Fidelity Disruptive Medicine ETF FMED Stock Holding History
Bought
Maintained
Sold
Other funds holding FMED
BFC Planning's FMED Position: Q3 2026 in Review
BFC Planning held its Fidelity Disruptive Medicine ETF (FMED) position steady in Q3 2026 at 350 shares worth $11.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2316.
BFC Planning first reported a position in FMED in Q1 2025 and has held it in 7 quarters since. 11 funds tracked by Wall St. Rank hold FMED as of Q3 2026.
- BFC Planning held 350 shares of Fidelity Disruptive Medicine ETF worth $11.3K as of Q3 2026.
- BFC Planning left its Fidelity Disruptive Medicine ETF share count unchanged in Q3 2026.
- Fidelity Disruptive Medicine ETF made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2316 holding.
- BFC Planning first reported a position in Fidelity Disruptive Medicine ETF in Q1 2025 and has held it in 7 quarters since.
- 11 funds tracked by Wall St. Rank held Fidelity Disruptive Medicine ETF as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.